Advertisement

Topics

PARP Inhibition Moves to Next Phase in Ovarian Cancer

10:13 EDT 10 Apr 2019 | OncLive

Chrisann Kyi, MD, discusses the utility of PARP inhibitors in the primary treatment and maintenance settings for patients with recurrent ovarian cancer and the next steps that lie ahead.

Original Article: PARP Inhibition Moves to Next Phase in Ovarian Cancer

NEXT ARTICLE

More From BioPortfolio on "PARP Inhibition Moves to Next Phase in Ovarian Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...